Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Folate-Related Nutrients, Genetic Polymorphisms, and Colorectal Cancer Risk: the Fukuoka Colorectal Cancer Study

  • Morita, Makiko (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University) ;
  • Yin, Guang (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University) ;
  • Yoshimitsu, Shin-Ichiro (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University) ;
  • Ohnaka, Keizo (Department of Geriatric Medicine, Graduate School of Medical Sciences, Kyushu University) ;
  • Toyomura, Kengo (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University) ;
  • Kono, Suminori (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University) ;
  • Ueki, Takashi (Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University) ;
  • Tanaka, Masao (Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University) ;
  • Kakeji, Yoshihiro (Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University) ;
  • Maehara, Yoshihiko (Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University) ;
  • Okamura, Takeshi (Department of Gastroenterological Surgery, National Kyushu Cancer Center) ;
  • Ikejiri, Koji (Division of Surgery, National Kyushu Medical Center) ;
  • Futami, Kitaroh (Department of Surgery, Fukuoka University Chikushi Hospital) ;
  • Maekawa, Takafumi (Department of Surgery, Fukuoka University Chikushi Hospital) ;
  • Yasunami, Yohichi (Department of Regenerative Medicine & Transplantation, Faculty of Medicine, Fukuoka University) ;
  • Takenaka, Kenji (Division of Surgery, Fukuoka City Hospital) ;
  • Ichimiya, Hitoshi (Hamanomachi General Hospital) ;
  • Terasaka, Reiji (Fukuoka Red Cross Hospital)
  • Published : 2013.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

One-carbon metabolism plays an important role in colorectal carcinogenesis. Meta-analyses have suggested protective associations of folate and vitamin $B_6$ intakes with colorectal cancer primarily based on studies in Caucasians, and genetic polymorphisms pertaining to the folate metabolism have been a matter of interest. Less investigated are the roles of methionine synthase (MTR) and thymidylate synthetase (TS) polymorphisms in colorectal carcinogenesis. In a study of 816 cases and 815 community controls in Japan, we investigated associations of dietary intakes of folate, methionine, vitamin $B_2$, vitamin $B_6$, and vitamin $B_{12}$ with colorectal cancer risk. The associations with MTR 2756A>G, MTRR 66A>G, and TSER repeat polymorphism were examined in 685 cases and 778 controls. Methionine and vitamin $B_{12}$ intakes were inversely associated with colorectal cancer risk, but the associations were totally confounded by dietary calcium and n-3 fatty acids. The other nutrients showed no association with the risk even without adjustment for calcium and n-3 fatty acids. The TSER 2R allele was dose-dependently associated with an increased risk. The MTR and MTRR polymorphisms were unrelated to colorectal cancer risk. There was no measurable gene-gene or gene-nutrient interaction, but increased risk associated with the TSER 2R allele seemed to be confined to individuals with high folate status. This study does not support protective associations for folate and vitamin $B_6$. The TSER 2R allele may confer an increased risk of colorectal cancer. The role of the TSER polymorphism in colorectal carcinogenesis may differ by ethnicity.

Keywords

References

  1. Chen J, Giovannucci E, Kelsey K, et al (1996). A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res, 56, 4862-4.
  2. Chen J, Hunter DJ, Stampfer MJ, et al (2003). Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 12, 958-62.
  3. De Vogel S, Wouters KA, Gottschalk RW, et al (2009). Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. Cancer Epidemiol Biomarkers Prev, 18, 3086-96. https://doi.org/10.1158/1055-9965.EPI-09-0289
  4. Ding W, Zhou DL, Jiang X, Lu LS (2013). Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies. PLoS One, 9, 60508.
  5. Eussen SJ, Vollset SE, Igland J, et al (2010). Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev, 19, 1328-40. https://doi.org/10.1158/1055-9965.EPI-09-0841
  6. Eussen SJ, Vollset SE, Hustad S, et al (2010). Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 19, 2549-61. https://doi.org/10.1158/1055-9965.EPI-10-0407
  7. Giovannucci E, Rimm EB, Ascherio A, et al (1995). Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst, 87, 265-73. https://doi.org/10.1093/jnci/87.4.265
  8. Harnack L, Jacobs DR Jr, Nicodemus K, et al (2002). Relationship of folate, vitamin B6, vitamin B12, and methionine intake to incidence of colorectal cancers. Nutr Cancer, 43, 152-8. https://doi.org/10.1207/S15327914NC432_5
  9. Huang Y, Han S, Li Y, Mao Y, Xie Y (2007). Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J Hum Genet, 52, 73-85.
  10. Hubner RA, Houlston RS (2007). MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations. Int J Cancer, 120, 1027-35.
  11. Hubner RA, Houlston RS (2009). Folate and colorectal cancer prevention. Br J Cancer, 100, 233-9. https://doi.org/10.1038/sj.bjc.6604823
  12. Ishihara J, Otani T, Inoue M, et al (2007). Low intake of vitamin B-6 is associated with increased risk of colorectal cancer in Japanese men. J Nutr, 137, 1808-14. https://doi.org/10.1093/jn/137.7.1808
  13. Isomura K, Kono S, Moore MA, et al (2006). Physical activity and colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci, 97, 1099-104. https://doi.org/10.1111/j.1349-7006.2006.00282.x
  14. Kennedy DA, Stern SJ, Moretti M, et al (2011). Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol, 35, 2-10. https://doi.org/10.1016/j.canep.2010.11.004
  15. Kim DH, Smith-Warner SA, Spiegelman D, et al (2010). Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control, 21, 1919-30. https://doi.org/10.1007/s10552-010-9620-8
  16. Kim J, Cho YA, Kim DH, et al (2012). Dietary intake of folate and alcohol, MTHFR C677T polymorphism, and colorectal cancer risk in Korea. Am J Clin Nutr, 95, 405-12. https://doi.org/10.3945/ajcn.111.020255
  17. Kim YI (2008). Folic acid supplementation and cancer risk: point. Cancer Epidemiol Biomarkers Prev, 17, 2220-5. https://doi.org/10.1158/1055-9965.EPI-07-2557
  18. Kimura Y, Kono S, Toyomura K, et al (2007). Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci, 98, 590-7. https://doi.org/10.1111/j.1349-7006.2007.00425.x
  19. Kono S, Toyomura K, Yin G, Nagano J, Mizoue T (2004). A case-control study of colorectal cancer in relation to lifestyle factors and genetic polymorphisms: design and conduct of the Fukuoka colorectal cancer study. Asian Pac J Cancer Prev, 5, 393-400.
  20. Kono S, Chen K (2005). Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci, 96, 535-42. https://doi.org/10.1111/j.1349-7006.2005.00090.x
  21. Larsson SC, Orsini N, Wolk A (2010). Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA, 303, 1077-83. https://doi.org/10.1001/jama.2010.263
  22. Le Marchand L, Donlon T, Hankin JH, et al (2002). B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control, 13, 239-48. https://doi.org/10.1023/A:1015057614870
  23. Le Marchand L, Wilkens LR, Kolonel LN, Henderson BE (2005). The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 14, 1198-203. https://doi.org/10.1158/1055-9965.EPI-04-0840
  24. Le Marchand L, White KK, Nomura AM, et al (2009). Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 18, 2195-201. https://doi.org/10.1158/1055-9965.EPI-09-0141
  25. Ma J, Stampfer MJ, Giovannucci E, et al (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res, 57, 1098-102.
  26. Ma J, Stampfer MJ, Christensen B, et al (1999). A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 8, 825-9.
  27. Mason JB, Choi SW (2005). Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol, 35, 235-41. https://doi.org/10.1016/j.alcohol.2005.03.012
  28. Matsuo K, Ito H, Wakai K, et al (2005). One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis, 26, 2164-71. https://doi.org/10.1093/carcin/bgi196
  29. Mizoue T, Kimura Y, Toyomura K, et al (2008). Calcium, dairy foods, vitamin D, and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Cancer Epidemiol Biomarkers Prev, 17, 2800-7. https://doi.org/10.1158/1055-9965.EPI-08-0369
  30. Murtaugh MA, Curtin K, Sweeney C, et al (2007). Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control, 18, 153-63. https://doi.org/10.1007/s10552-006-0099-2
  31. Razzak AA, Oxentenko AS, Vierkant RA, et al (2012). Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa women’s health study. Nutr Cancer, 64, 899-910. https://doi.org/10.1080/01635581.2012.714833
  32. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ (2005). Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer, 113, 825-8. https://doi.org/10.1002/ijc.20648
  33. Sharp L, Little J (2004). Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol, 159, 423-43. https://doi.org/10.1093/aje/kwh066
  34. Sharp L, Little J, Brockton NT, et al (2008). Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case-control study in a population with relatively low folate intake. Br J Nutr, 99, 379-89.
  35. Shrubsole MJ, Yang G, Gao YT, et al (2009). Dietary B vitamin and methionine intakes and plasma folate are not associated with colorectal cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev, 18, 1003-6. https://doi.org/10.1158/1055-9965.EPI-08-1200
  36. Stevens VL, McCullough ML, Sun J, et al (2011). High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer. Gastroenterology, 141, 98-105 https://doi.org/10.1053/j.gastro.2011.04.004
  37. Theodoratou E, Farrington SM, Tenesa A, et al (2008). Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 17, 171-82. https://doi.org/10.1158/1055-9965.EPI-07-0621
  38. Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW (2002). Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet, 111, 299-302. https://doi.org/10.1007/s00439-002-0779-2
  39. Uchida K, Kimura Y, Shirota T, Kono S (2007). Validity and reproducibility of the PC-assisted dietary interview used in the Fukuoka colorectal cancer study. Asian Pac J Cancer Prev, 8, 583-90.
  40. Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD (2002). Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res, 62, 3361-4.
  41. Ulrich CM (2005). Nutrigenetics in cancer research: folate metabolism and colorectal cancer. J Nutr, 135, 2698-702. https://doi.org/10.1093/jn/135.11.2698
  42. Ulrich CM, Curtin K, Potter JD, et al (2005). Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 14, 2509-16. https://doi.org/10.1158/1055-9965.EPI-05-0261
  43. Ulvik A, Vollset SE, Hansen S, et al (2004). Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev, 13, 2175-80.
  44. Van Guelpen B, Hultdin J, Johansson I, et al (2006). Low folate levels may protect against colorectal cancer. Gut, 55, 1461-6. https://doi.org/10.1136/gut.2005.085480
  45. Weinstein SJ, Albanes D, Selhub J, et al (2008). One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Biomarkers Prev, 17, 3233-40. https://doi.org/10.1158/1055-9965.EPI-08-0459
  46. Willett W, Stampfer MJ (1986). Total energy intake: implications for epidemiologic analyses. Am J Epidemiol, 124, 17-27. https://doi.org/10.1093/oxfordjournals.aje.a114366
  47. Williams EA (2012). Folate, colorectal cancer and the involvement of DNA methylation. Proc Nutr Soc, 71, 592-7. https://doi.org/10.1017/S0029665112000717
  48. Winder T, Lenz HJ (2010). Molecular predictive and prognostic markers in colon cancer. Cancer Treat Rev, 36, 550-6. https://doi.org/10.1016/j.ctrv.2010.03.005
  49. Yang Z, Zhang XF, Liu HX, Hao YS, Zhao CL (2012). MTHFR C677T polymorphism and colorectal cancer risk in Asians, a meta-analysis of 21 studies. Asian Pac J Cancer Prev, 13, 1203-8. https://doi.org/10.7314/APJCP.2012.13.4.1203
  50. Yin G, Kono S, Toyomura K, et al (2004). Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci, 95, 908-13. https://doi.org/10.1111/j.1349-7006.2004.tb02201.x
  51. Zhang X, Lee JE, Ma J, et al (2012). Prospective cohort studies of vitamin $B_{6}$ intake and colorectal cancer incidence: modification by time? Am J Clin Nutr, 96, 874-81. https://doi.org/10.3945/ajcn.112.037267
  52. Zschabitz S, Cheng TY, Neuhouser ML,et al (2013). B vitamin intakes and incidence of colorectal cancer: results from the women’s health initiative observational study cohort. Am J Clin Nutr, 97, 332-43. https://doi.org/10.3945/ajcn.112.034736

Cited by

  1. C1420T Polymorphism of Cytosolic Serine Hydroxymethyltransferase and Risk of Cancer: a Meta-analysis vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2257
  2. Proteomic Analysis of One-carbon Metabolism-related Marker in Liver of Rat Offspring vol.14, pp.11, 2015, https://doi.org/10.1074/mcp.M114.046888
  3. Associations between Vitamin D Receptor (VDR) Gene Polymorphisms and Colorectal Cancer Risk and Effect Modifications of Dietary Calcium and Vitamin D in a Japanese Population vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.2019
  4. Gene-Diet Interactions and Their Impact on Colorectal Cancer Risk vol.4, pp.1, 2015, https://doi.org/10.1007/s13668-014-0114-2
  5. Methionine Synthase Reductase Polymorphism in Colorectal Cancer: A Systematic Review and Meta-Analysis vol.7s1, pp.1179-299X, 2015, https://doi.org/10.4137/BIC.S25251
  6. Thymidylate Synthase Polymorphisms and Risk of Lung Cancer among the Jordanian Population: a Case Control Study vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8287
  7. A dose–response meta-analysis reveals an association between vitamin B12 and colorectal cancer risk vol.19, pp.08, 2016, https://doi.org/10.1017/S136898001500261X
  8. rs1801133 in colorectal cancer: a case–control study and meta-analysis vol.18, pp.11, 2017, https://doi.org/10.2217/pgs-2017-0030
  9. TSER polymorphism is not associated with risk of pediatric acute lymphoblastic leukemia vol.96, pp.7, 2017, https://doi.org/10.1097/MD.0000000000006143
  10. Vitamin B2 intake reduces the risk for colorectal cancer: a dose–response analysis pp.1436-6215, 2018, https://doi.org/10.1007/s00394-018-1702-5